The research group of Joan X. Comella focuses on characterizing and understanding the molecular mechanisms of certain proteins that block cell death in the nervous system. This cell death is often associated with neuroinflammatory processes. “These proteins protect neurons from cell death,” explained Comella framed in a lecture in the series of seminars IDIBELL on 17 June.
The leader of the research group on Toxicity of sensory and motor systems at IDIBELL and Professor of Physiology at the University of Barcelona, Jordi Llorens has been named president of the International Neurotoxicology Association within the framework of the international neurotoxicology conference that the association has organized on June 5-10th in Xian, China. The
Jordi Llorens named president of the International Neurotoxicology Association Read More »
On 6 June the Institute for Bioengineering of Catalonia (IBEC) presented its activities to IDIBELL biomedical researchers, as part of the official agreement of collaboration between both institutes, in a conference organized by the Biopol’H.
IBEC presents its activities to IDIBELL researchers Read More »
The pediatrician and oncologist Manuel Ramírez explained at a conference in the past IDIBELL June 10 his clinical experience in children with solid tumors treated with the virus ICOVIR 5, designed by the research group on virotherapy of the IDIBELL led by Ramon Alemany, in the Unit of Pediatric Hematology and Oncology of the Hospital Niño Jesús in Madrid where he heads a research group for developing new therapies for children with cancer.
IDIBELL has added a new scientific platform which increases applications of Biomark, an equipment purchased a year ago that performs real-time PCR, gene expression, genotyping, and digital analysis of a large number of samples. The new platform, called Access Array System, enables to obtain the number of PCR amplifications needed to sequence the samples with the new technology Next Generation Sequencing System with a great reduction of time and costs.
IDIBELL has a new platform that facilitates the use of ultrasequencing technology Read More »
The head of the research group on apoptosis and cancer of the IDIBELL, and professor of biochemistry and molecular biology at the University of Barcelona, Joan Gil, has been awarded the I Fundación Valdés-Salas Award in Applied Biomedicine. The jury decided unanimously to grant this award to Joan Gil for his research in finding new treatments for leukemia and lymphoma in B cells.
Researcher Joan Gil wins Valdés-Salas award in applied biomedicine Read More »
During the process of immune recognition, T cells and antigen-presenting cells exchange genetic information (microRNA), which allows modify the immune behavior. The researcher of the institute of health research of La Princesa Hospital, in Madrid, Francisco Sánchez-Madrid explained his recent work on processes that lead to the immune response during an IDIBELL seminar on 3rd June in the conference hall of the Duran i Reynals Hospital (ICO).
Francisco Sánchez-Madrid: ”The immune cells exchange genetic material” Read More »
IDIBELL researcher at Catalan Institute of Oncology (ICO) Silvia de Sanjosé has taken part in sequencing the genome of chronic lymphocytic leukemia. The research, led by the researcher of the Institute of Biomedical Research August Pi i Sunyer (IDIBAPS) Elias Campo, is published in the latest issue of the journal Nature. The results of this
IDIBELL researcher takes part in sequencing the genome of chronic lymphocytic leukemia Read More »
Patients with aphasia (loss of ability to understand or produce language) are able to recover language skills through the same mechanisms that allow children to learn to speak. Complex activity About Dobel
